ÂÜÀòÂÒÂ×

Patricia has over thirty year of experience in finance including start-ups as well as publicly traded companies. In her current role as CFO at Nano PharmaSolutions, she is a member of the leadership team developing and executing on financing strategy and responsible for developing administrative operational infrastructure supporting the dynamic growth of the company.

Prior to joining Nano PharmaSolutions, Patricia spent a decade at Pfenex Inc.. (PFNX), beginning with the spin out of the novel protein production platform from the Dow Chemical Company into a stand-alone biotechnology company. She was instrumental in developing and executing on Pfenex’s financial strategy that included an IPO and provided the capital needed to obtain FDA approval on its lead candidate and eventual final exit through acquisition.

Prior to Pfenex Inc, Patricia led finance and corporate development teams in the life science and technology industries of various start-ups and publicly traded companies.

Patricia received her MBA from the University of California, Los Angeles. She holds an active CPA license in the State of California.